Lung infection drug cayston fails to prove benefit in bronchiectasis trial
Disease control
Terminated
This study tested the drug Cayston (aztreonam lysine) in adults with bronchiectasis, a chronic lung disease causing cough and frequent infections. The goal was to see if the drug could safely delay the next lung infection. The trial was stopped early after enrolling only 34 of th…
Phase: PHASE4 • Sponsor: University of Dundee • Aim: Disease control
Last updated May 13, 2026 16:02 UTC